- Investing Ideas
- /
- Malaysian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Malaysian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
1
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
DPHARMA | RM 1.25 | -0.8% | -0.8% | RM 1.2b | RM 1.45 | PE21.4x | E23.0% | 2.2% |
Page 1 of 1